Previous 10 | Next 10 |
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the second quarter ended July 3, 2020 on Wednesday, August 5, 2020 after t...
STAAR Surgical Company (NASDAQ: STAA) today announced that to support the health and well-being of its shareholders, employees, directors, and communities due to the public health threat of the COVID-19 pandemic the Company’s upcoming 2020 Annual Meeting of Shareholders (the “An...
Receives CE Mark Approval from European Notified Body EVO Viva Implantable Collamer® Lens Corrects Near, Intermediate and Distance Vision STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery sys...
The move is effective from today. More news on: STAAR Surgical Company, Consumer stocks news, Read more ...
Deborah Andrews to Remain in Advisory Role During Transition STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that Patrick F. Williams has joined the Company as Chief ...
June holds plenty of catalysts for biotechnology stocks -- especially those specializing in cancer treatments. Investors with extra cash on the sidelines may be able to capture some exciting cancer stocks at attractive prices. These small-cap biotechnology stocks when held in the long term can...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the appointment of Gilbert H. Kliman, M.D., Managing Partner, InterWest Partners and Thomas G. Frinzi, former Worldwide Presi...
STAAR Surgical Co (STAA) Q1 2020 Earnings Conference Call May 06, 2020, 16:30 ET Company Participants Brian Moore - VP, Investor, Media Relations & Corporate Development Caren Mason - CEO, President & Director Deborah Andrews - CFO Conference Call Participants Cecil...
Image source: The Motley Fool. Staar Surgical Co (NASDAQ: STAA) Q1 2020 Earnings Call May 6, 2020 , 4:30 p.m. ET Operator Continue reading
STAAR Surgical (NASDAQ: STAA ): Q1 Non-GAAP EPS of $0.04 beats by $0.01 ; GAAP EPS of $0.00 beats by $0.04 . More news on: STAAR Surgical Company, Earnings news and commentary, Consumer stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
STAAR Surgical Company Company Name:
STAA Stock Symbol:
NASDAQ Market:
STAAR Surgical Company Website:
2024-07-14 17:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with Patrick F. Will...
2024-05-24 07:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...